|From: hunter1 (Rep: 466)||Date: 02/10/2020 11:24|
|Forum: Ocugen - Msg #129||Thread #674122223 (Rec: 0) |
|MALVERN, Pa., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, today announced it will present at NobleCon16 - Noble Capital Markets’ Sixteenth Annual Investor Conference, to be held February 17-18, 2020 in Hollywood, Florida.|
any stock i buy or sell could be halted and go to zero at any time.if you can not lose it dont trade it.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.